Connection

Paola Rogliani to Forced Expiratory Volume

Back to Details
This is a "connection" page, showing publications Paola Rogliani has written about Forced Expiratory Volume.
Paola Rogliani
Connection Strength
0.430
Forced Expiratory Volume
  1. Monoclonal antibodies in severe asthma: is it worth it? Expert Opin Drug Metab Toxicol. 2019 Jun; 15(6):517-520.
    View in: PubMed
    Score: 0.155
  2. Withdrawal of inhaled corticosteroids in COPD: A meta-analysis. Pulm Pharmacol Ther. 2017 08; 45:148-158.
    View in: PubMed
    Score: 0.135
  3. Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes. J Allergy Clin Immunol Pract. 2019 May - Jun; 7(5):1643-1646.
    View in: PubMed
    Score: 0.038
  4. Impact of doxofylline in COPD: A pairwise meta-analysis. Pulm Pharmacol Ther. 2018 08; 51:1-9.
    View in: PubMed
    Score: 0.036
  5. Impact of LABA/LAMA combination on exercise endurance and lung hyperinflation in COPD: A pair-wise and network meta-analysis. Respir Med. 2017 08; 129:189-198.
    View in: PubMed
    Score: 0.034
  6. LABA/LAMA combination in COPD: a meta-analysis on the duration of treatment. Eur Respir Rev. 2017 Jan; 26(143).
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.